4 min read
Tracking mRNA from Efficacy to Effectiveness
Recent news around the promising mRNA vaccines targeting cancers results indeed caused great excitement in many...
May 25, 2023 by John Varaklis
Recent news around the promising mRNA vaccines targeting cancers results indeed caused great excitement in many...
May 15, 2023 by Steve Steinhubl, MD
The recent wave of public interest in several groundbreaking studies of mRNA vaccines in the treatment of cancer are...
Oct 20, 2022 by Karen Larimer, PhD, ACNP-BC, FAHA
Prevention, early detection, and vigilant patient monitoring are critical elements in successfully and cooperatively...
Sep 20, 2022 by Gary Conkright
98.6 degrees, 120 over 80, 72 beats per minute – standard vital signs we have known since our first memorable visit to...
Nov 21, 2019 by Lacey Conley, PhD, RTE. CSM
In the coming weeks, physIQ is transitioning from feature-based Agile software development into time-based releases...
Nov 19, 2019 by Karen Larimer, PhD, ACNP-BC, FAHA
When it comes to technology development, I am consistently surprised by how little actual user-testing is done. And by...
Jan 27, 2023 by John Varaklis
Originally published in Medical Device & Technology
John Varaklis, chief strategy officer for physIQ, discusses the...
Jan 3, 2023 by Matt Pipke
Originally published in Pixel Scientia Labs
In this episode, I talk with Matt Pipke, Co-founder and Chief Digital...
Dec 16, 2022 by physIQ
Originally published in Crain's Chicago
COMPANY SEES PROMISE IN ADDING AI TO CARDIOPULMONARY TESTS: Chicago-based...
Dec 16, 2022 by physIQ
Originally published in BioWorld MedTech
By Annette Boyle
The move away from in-clinic testing continues, with another...
Dec 14, 2022 by physIQ
.
Innovative approach can deliver high-fidelity cardiopulmonary exercise test results comparable to gold-standard...
Dec 13, 2022 by physIQ
Originally published in PharmaVoice
Chris EnglerthVice president, marketing, physIQ
“It’s got to be...